Article Details

Magenta Therapeutics (NASDAQ:MGTA) Rating Lowered to Strong Sell at BidaskClub

Retrieved on: 2020-11-11 07:48:32

Tags for this article:

Click the tags to see associated articles and topics

Magenta Therapeutics (NASDAQ:MGTA) Rating Lowered to Strong Sell at BidaskClub. View article details on hiswai:

Excerpt

<b>Morgan Stanley</b> now owns 276,750 shares of the company's stock worth $1,881,000 after purchasing an additional 62,252 shares in the last quarter.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up